These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10439880)

  • 1. Glucose-insulin-potassium (GIK) for acute myocardial infarction: a negative study with a positive value.
    Apstein CS; Opie LH
    Cardiovasc Drugs Ther; 1999 May; 13(3):185-9. PubMed ID: 10439880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose glucose-insulin-potassium treatment reduces myocardial apoptosis in patients with acute myocardial infarction.
    Zhang L; Zhang L; Li YH; Zhang HY; Chen ML; Gao MM; Hu AH; Yang HS; Yang HS
    Eur J Clin Invest; 2005 Mar; 35(3):164-70. PubMed ID: 15733070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.
    Díaz R; Goyal A; Mehta SR; Afzal R; Xavier D; Pais P; Chrolavicius S; Zhu J; Kazmi K; Liu L; Budaj A; Zubaid M; Avezum A; Ruda M; Yusuf S
    JAMA; 2007 Nov; 298(20):2399-405. PubMed ID: 18042917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.
    Mehta SR; Yusuf S; Díaz R; Zhu J; Pais P; Xavier D; Paolasso E; Ahmed R; Xie C; Kazmi K; Tai J; Orlandini A; Pogue J; Liu L;
    JAMA; 2005 Jan; 293(4):437-46. PubMed ID: 15671428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy with glucose-insulin-potassium reduces the complications in the acute phase of myocardial infarct. Arguments in favor].
    Alegría Ezquerra E; Maceria González A
    Rev Esp Cardiol; 1998 Sep; 51(9):720-6. PubMed ID: 9803797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial.
    Ceremuzyński L; Budaj A; Czepiel A; Burzykowski T; Achremczyk P; Smielak-Korombel W; Maciejewicz J; Dziubińska J; Nartowicz E; Kawka-Urbanek T; Piotrowski W; Hanzlik J; Cieśliński A; Kawecka-Jaszcz K; Gessek J; Wrabec K
    Cardiovasc Drugs Ther; 1999 May; 13(3):191-200. PubMed ID: 10439881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-insulin-potassium solution for acute myocardial infarction.
    Janiger JL; Cheng JW
    Ann Pharmacother; 2002 Jun; 36(6):1080-4. PubMed ID: 12022912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group.
    Díaz R; Paolasso EA; Piegas LS; Tajer CD; Moreno MG; Corvalán R; Isea JE; Romero G
    Circulation; 1998 Nov; 98(21):2227-34. PubMed ID: 9867443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-insulin-potassium therapy in the era of coronary revascularization.
    Leos CL; Griego JE; Anderson JR
    Cardiol Rev; 2005; 13(5):266-70. PubMed ID: 16106190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of glucose-insulin-potassium and insulin-glucose as adjunctive therapy in acute myocardial infarction: a contemporary meta-analysis of randomised controlled trials.
    Zhao YT; Weng CL; Chen ML; Li KB; Ge YG; Lin XM; Zhao WS; Chen J; Zhang L; Yin JX; Yang XC
    Heart; 2010 Oct; 96(20):1622-6. PubMed ID: 20937749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of high dose glucose-insulin-potassium infusion in patients with acute ST-segment elevation myocardial infarction: analysis of 7510 patients in China as part of CREATE-ECLA study].
    Yang YM; Zhu J; Tan HQ; Liang Y; Zhang Y; Li Y; Li JD; Liu LS;
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1806-10. PubMed ID: 19040013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forty years of glucose-insulin-potassium (GIK) in cardiac surgery: a review of randomized, controlled trials.
    Schipke JD; Friebe R; Gams E
    Eur J Cardiothorac Surg; 2006 Apr; 29(4):479-85. PubMed ID: 16481185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of glucose-insulin-potassium solution on ventricular late potentials and heart rate variability in acute myocardial infarction.
    Ulgen MS; Alan S; Akdemir O; Toprak N
    Coron Artery Dis; 2001 Sep; 12(6):507-12. PubMed ID: 11696690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-insulin-potassium infusion as adjunctive therapy in myocardial infarction: current evidence and potential mechanisms.
    Timmer JR; van der Horst IC; Ottervanger JP; De Luca G; van 't Hof AW; Bilo HJ; Zijlstra F
    Ital Heart J; 2004 Oct; 5(10):727-31. PubMed ID: 15626267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion.
    Rogers WJ; Stanley AW; Breinig JB; Prather JW; McDaniel HG; Moraski RE; Mantle JA; Russell RO; Rackley CE
    Am Heart J; 1976 Oct; 92(4):441-54. PubMed ID: 785990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic modulation of acute myocardial infarction.
    Diaz R
    Crit Care Clin; 2001 Apr; 17(2):469-76. PubMed ID: 11450327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is justified the use of GIK solutions in acute myocardial infarct?].
    de Micheli A
    Arch Cardiol Mex; 2008; 78(3):243-6. PubMed ID: 18959010
    [No Abstract]   [Full Text] [Related]  

  • 18. Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: the CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction.
    Yusuf S; Mehta SR; Díaz R; Paolasso E; Pais P; Xavier D; Xie C; Ahmed RJ; Khazmi K; Zhu J; Liu L;
    Am Heart J; 2004 Dec; 148(6):1068-78. PubMed ID: 15632895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-insulin-potassium (GIK) therapy for ischemic heart disease.
    Kones RJ; Phillips JH
    Crit Care Med; 1975; 3(4):143-54. PubMed ID: 1104262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced preservation of acutely ischemic myocardium and improved clinical outcomes using glucose-insulin-potassium (GIK) solutions.
    Lazar HL
    Am J Cardiol; 1997 Aug; 80(3A):90A-93A. PubMed ID: 9293960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.